F-star

Merck, F-Star ink research agreement

Wednesday, September 7, 2011

Merck Serono, Darmstadt, Germany, has reported that a research, license and commercialization agreement was signed with F-Star, Vienna, Austria, for the discovery of new antibody-derived therapeutics against inflammatory disease targets, using F-Star’s Modular Antibody Technology.

[Read More]